Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, With Implications for Combined Therapy in Ovarian Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-14-1801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Broadly Neutralizing Antibodies for Therapy of Viral Infections

Antibody Technology Journal
2016English

Combined Therapy With EGFR TKI and Gambogic Acid for Overcoming Resistance in EGFR‑T790M Mutant Lung Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Antibodies Neutralizing Hepsin Protease Activity Do Not Impact Cell Growth but Inhibit Invasion of Prostate and Ovarian Tumor Cells in Culture

Cancer Research
Cancer ResearchOncology
2006English

Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2016English

Development of EGFR-Targeted Nanoemulsion for Imaging and Novel Platinum Therapy of Ovarian Cancer

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2014English

Tumor Attenuation by Combined Heparan Sulfate and Polyamine Depletion

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Cancer Research
Cancer ResearchOncology
2017English

Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR

Cancer Research
Cancer ResearchOncology
2018English

Novel Targeting Strategies Using Recombinant Antibodies for Early Diagnosis and Therapy of Ovarian Cancer

Therapy
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy